Evidence map›Paper›PMID 19960564›Full record

ArticleWorld journal of gastroenterology2009

Nicotinamide overload may play a role in the development of type 2 diabetes.

Shi-Sheng Zhou, Da Li, Wu-Ping Sun, Ming Guo, Yong-Zhi Lun, Yi-Ming Zhou, Fu-Cheng Xiao, Li-Xin Jing, Shen-Xia Sun, Li-Bin Zhang and 12 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 80 citations in OpenAlex.

  1. Trial
  2. Article
  3. The role of vitamins and nutrients in rosacea.Archives of dermatological research · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Hypoglycemic activity of the ethyl acetate extract fromIranian journal of basic medical sciences · 2020
    Article
  12. Impaired nicotinamide adenine dinucleotide (NADJournal of diabetes investigation · 2020
    Review
  13. Review
  14. Article
  15. Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.Metabolomics : Official journal of the Metabolomic Society · 2019
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 3 countries.

Shi-Sheng ZhouInstitute of Basic Medical Sciences, Medical College, Dalian University, Dalian, Liaoning Province, China. zhouss@ymail.com
Da Li
Wu-Ping Sun
Ming Guo
Yong-Zhi Lun
Yi-Ming Zhou
Fu-Cheng Xiao
Li-Xin Jing
Shen-Xia Sun
Li-Bin Zhang
Ning Luo
Fu-Ning Bian
Wei Zou
Lai-Bin Dong
Zhi-Gang Zhao
Sheng-Fan Li
Xiao-Jie Gong
Zeng-Guo Yu
Chang-Bin Sun
Cong-Long Zheng
Dong-Ju Jiang
Zheng-Ning Li
Liaoning Normal University · CNDalian University · CNOkazaki Institute for Integrative Bioscience · JPJiaozuo University · CNNational Institutes of Natural Sciences · JPNational Natural Science Foundation of China · CNUniversity of Louisville · USXinxiang Medical University · CNDalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate whether nicotinamide overload plays a role in type 2 diabetes.

methodsNicotinamide metabolic patterns of 14 diabetic and 14 non-diabetic subjects were compared using HPLC. Cumulative effects of nicotinamide and N(1)-methylnicotinamide on glucose metabolism, plasma H(2)O(2) levels and tissue nicotinamide adenine dinucleotide (NAD) contents of adult Sprague-Dawley rats were observed. The role of human sweat glands and rat skin in nicotinamide metabolism was investigated using sauna and burn injury, respectively.

resultsDiabetic subjects had significantly higher plasma N(1)-methylnicotinamide levels 5 h after a 100-mg nicotinamide load than the non-diabetic subjects (0.89 +/- 0.13 micromol/L vs 0.6 +/- 0.13 micromol/L, P < 0.001). Cumulative doses of nicotinamide (2 g/kg) significantly increased rat plasma N(1)-methylnicotinamide concentrations associated with severe insulin resistance, which was mimicked by N(1)-methylnicotinamide. Moreover, cumulative exposure to N(1)-methylnicotinamide (2 g/kg) markedly reduced rat muscle and liver NAD contents and erythrocyte NAD/NADH ratio, and increased plasma H(2)O(2) levels. Decrease in NAD/NADH ratio and increase in H(2)O(2) generation were also observed in human erythrocytes after exposure to N(1)-methylnicotinamide in vitro. Sweating eliminated excessive nicotinamide (5.3-fold increase in sweat nicotinamide concentration 1 h after a 100-mg nicotinamide load). Skin damage or aldehyde oxidase inhibition with tamoxifen or olanzapine, both being notorious for impairing glucose tolerance, delayed N(1)-methylnicotinamide clearance.

conclusionThese findings suggest that nicotinamide overload, which induced an increase in plasma N(1)-methylnicotinamide, associated with oxidative stress and insulin resistance, plays a role in type 2 diabetes.

Indexed as

AdultAgedAldehyde OxidaseAnimalsBlood GlucoseDiabetes Mellitus, Type 2ErythrocytesFemaleHumansHydrogen PeroxideInsulinMaleMiddle AgedNADNiacinamideOxidantsAldehyde OxidaseBlood GlucoseHydrogen PeroxideInsulinN(1)-methylnicotinamideNADNiacinamideOxidants

Identifiers

PMID19960564
PMCPMC2789220
OpenAlexW2168953878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.